Insilico Medicine Partners with Inimmune to Revolutionize Immunotherapeutic Discovery

Insilico Medicine Partners with Inimmune to Revolutionize Immunotherapeutic Discovery In a groundbreaking move set to reshape the landscape of immunotherapeutic discovery, Insilico Medicine, a clinical-stage biotechnology company renowned for its innovative use of artificial intelligence, has announced a strategic collaboration with Inimmune. This partnership is designed to leverage Insilico’s proprietary generative AI technology to accelerate […]